TLP Group’s Dimension Therapeutics, Inc DMTX Stock Holding History

TLP Group’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,891	Closed	-$71K	–	420
2016 Q3	$71K	Buy	+8,891	New	+$64.3K	0.08%	252

Other funds holding DMTX

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

TLP Group's DMTX Position: Q4 2016 in Review

TLP Group sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2016, closing a stake of 8,891 shares — an estimated $71K sold.

TLP Group first reported a position in DMTX in Q3 2016 and held it in 1 quarter. The position peaked at $71K in Q3 2016. 55 funds tracked by Wall St. Rank hold DMTX as of Q4 2016.

TLP Group reported no remaining Dimension Therapeutics, Inc position as of Q4 2016 after selling out during the quarter.
TLP Group sold 8,891 Dimension Therapeutics, Inc shares in Q4 2016, an estimated $71K.
TLP Group first reported a position in Dimension Therapeutics, Inc in Q3 2016 and held it in 1 quarter.
TLP Group's Dimension Therapeutics, Inc position peaked at $71K in Q3 2016.
55 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2016.

Based on TLP Group's 13F filing for Q4 2016, filed 2 Feb 2017.